Jana Partners Sees Transformation In Pharma; Targets JNPR

HFA Padded
Published on
Updated on

Jana Partners is making headlines again, this time for pressuring Juniper Networks, Inc. (NYSE:JNPR) with their shareholder activism, but not every relationship the group has with management teams is so adversarial. In fact, according to the latest performance update for the Jana Partners Master Fund, a copy of which was obtained by ValueWalk, there appears to be a transformation going on in the pharma industry. “Endo Health Solutions Inc (NASDAQ:ENDP) was the third largest contributor to performance in the quarter and a top 15 contributor for the year,” the company wrote. Jana Partners started watching Endo Health Solutions in January and…

This content is exclusively for paying members of Hedge Fund Alpha

Log In

Insider Strategies and Letters to Shareholders from the Top Hedge Funds and Maximize Your Portfolio Growth with Hedge Fund Alpha

Don’t have an account?

Subscribe now and get 7 days free!